Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
05/2001
05/23/2001EP0669827B1 Compositions for the regulation of cytokine activity
05/23/2001DE19955476A1 Bis-basische Verbindungen als Tryptase-Inhibitoren, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel Bis-basic compounds as tryptase inhibitors, to processes for their preparation and their use as medicaments
05/23/2001CN1296492A Fatty acid derivatives of bile acids and bile acid derivatives
05/23/2001CN1296488A Bicycle hydroxamic acid derivatives
05/23/2001CN1296481A (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides
05/23/2001CN1296478A Histamine H3 receptor ligands
05/23/2001CN1296474A Process for alkylating hindered sulfonamides useful in the production of matrix metalloproteinase inhibitors
05/23/2001CN1296011A Purine L-nucleoside, its analogue and use thereof
05/23/2001CN1296010A Novel cyano-indole thrombotonin reuptaking inhibitor compound, its preparation process and medicinal compositions having the same
05/23/2001CN1295858A Process for preparation of medicine of treat ulcerative colitis
05/23/2001CN1295851A Medicinal composition for treating cholecystitis and cholecystolithiasis and preparation process thereof
05/23/2001CN1295846A Earthworm compound capsule
05/23/2001CN1295845A Traditional Chinese medicine for treating burn and scald and preparation process thereof
05/23/2001CN1295842A Shenxian kidney-invigrating extract
05/23/2001CN1295841A Adhesive plaster for osteophytosis
05/23/2001CN1295837A Jinlan Chinese herbal medicine prescription for treating hepatitis B
05/23/2001CN1295835A Compound medicine for treating hyperhydrochloria
05/23/2001CN1066246C Axial flow valve system for linear compressor
05/23/2001CN1066150C Bridged indole as matrix metalloprotease inhibitors
05/23/2001CN1066063C Traditional Chinese medicine for treating infantile diarrhea
05/23/2001CN1066062C Medicine for gastroenteritic diseases and its preparation process
05/23/2001CN1066058C Oral liquid for treating lamb scours and preparation process thereof
05/23/2001CN1066052C Gastric medicine
05/23/2001CN1066048C Spleen tonifying intelligence improving granule for children
05/22/2001US6235970 CICM cells and non-human mammalian embryos prepared by nuclear transfer of a proliferating differentiated cell or its nucleus
05/22/2001US6235969 Cloning pigs using donor nuclei from non-quiescent differentiated cells
05/22/2001US6235756 Methods and compositions for inhibition of angiogenesis by thalidomide
05/22/2001US6235750 Nitric oxide synthase inhibitor
05/22/2001US6235747 6-phenyl-pyridin-2-ylamine derivatives
05/22/2001US6235745 Use of 5HT3, antagonists for promoting intestinal lavage
05/22/2001US6235742 5-substituted pyrazolo[4,3-D]pyrimidin-7-ones
05/22/2001US6235735 Aftertreatment of radiation therapy
05/22/2001US6235734 Pyridone-fused azabicyclic- or cytisine derivatives, their preparation and their use in addiction therapy
05/22/2001US6235732 Neurokinin antagonists
05/22/2001US6235723 Antisense oligonucleotide modulation of human protein kinase C-δ expression
05/22/2001US6235717 Pharmaceutical compounds
05/22/2001US6235287 Extract of curcuma amada plant and a compound selected from ocimene, dihydro-ocimene, piene/a-/, curcumene-alpha and beta, linalool, cuminyl alcohol, keto-alchol, turmerone, linalyl acetate, ssfrole, carene-3, myrcene, cineol, limonene
05/22/2001CA2217006C Novel substituted piperazine derivatives having tachykinin receptor antagonists activity
05/17/2001WO2001034800A1 19 human secreted proteins
05/17/2001WO2001034768A2 15 human secreted proteins
05/17/2001WO2001034767A2 22 human secreted proteins
05/17/2001WO2001034643A1 24 human secreted proteins
05/17/2001WO2001034629A1 21 human secreted proteins
05/17/2001WO2001034628A1 35 human secreted proteins
05/17/2001WO2001034627A1 28 human secreted proteins
05/17/2001WO2001034623A1 29 human secreted proteins
05/17/2001WO2001034614A2 Compositions and methods for double-targeting virus infections and targeting cancer cells
05/17/2001WO2001034610A1 Polycycloalkylpurines as adenosine receptor antagonists
05/17/2001WO2001034607A1 Pdgf receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same
05/17/2001WO2001034606A1 Pharmaceutically active isoindoline derivatives
05/17/2001WO2001034605A1 SUBSTITUTED 2-ARYL-3-(HETEROARYL)-IMIDAZO[1,2-a]PYRIMIDINES, AND RELATED PHARMACEUTICAL COMPOSITIONS AND METHODS
05/17/2001WO2001034604A2 Adenosine receptor antagonists and methods of making and using the same
05/17/2001WO2001034601A2 Imidazopyridine derivatives as phosphodiesterase vii inhibitors
05/17/2001WO2001034600A1 Protease inhibitors
05/17/2001WO2001034599A1 Protease inhibitors
05/17/2001WO2001034593A1 Compound with growth hormone releasing properties
05/17/2001WO2001034591A2 Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof
05/17/2001WO2001034578A1 Compounds with anti-helicobacter pylori activity
05/17/2001WO2001034573A1 Compounds
05/17/2001WO2001034572A2 Carboxamide-substituted benzimidazol derivatives, method for the production thereof and their use as tryptase inhibitors
05/17/2001WO2001034569A1 Pancreatitis remedies
05/17/2001WO2001034566A2 Protease inhibitors
05/17/2001WO2001034565A2 Protease inhibitors
05/17/2001WO2001034562A1 Aralkyl-1,2-diamines having calcimimetic activity and preparation mode
05/17/2001WO2001034182A2 Composition for treating respiratory tract infections containing menthol, eucalyptol and an alpha-amylase
05/17/2001WO2001034175A2 Methods of treating inflammatory bowel disease using cholera toxin b subunit
05/17/2001WO2001034168A1 Inhibition of pathogens by bacillus coagulans strains
05/17/2001WO2001034165A1 Therapeutic compositions and methods of use thereof
05/17/2001WO2001034160A1 Protease inhibitors
05/17/2001WO2001034159A1 Protease inhibitors
05/17/2001WO2001034158A1 Protease inhibitors
05/17/2001WO2001034157A1 Protease inhibitors
05/17/2001WO2001034156A1 Protease inhibitors
05/17/2001WO2001034155A1 Protease inhibitors
05/17/2001WO2001034154A1 Protease inhibitors
05/17/2001WO2001034153A1 Protease inhibitors
05/17/2001WO2001034143A1 Preventive or therapeutic agents for inflammatory diseases of intestine
05/17/2001WO2001034141A1 Il-8 receptor antagonists
05/17/2001WO2001034139A1 Pharmaceutical formulation containing tolterodine and its use
05/17/2001WO2001034125A2 Therapeutic use and formulation of (-)-tramadol
05/17/2001WO2001033975A1 Nutritional compositions which contain non-digestible polysaccharides and use thereof to reduce transport through tight junctions
05/17/2001WO2001012598A9 METHODS OF INHIBITING BINDING OF β-SHEET FIBRIL TO RAGE AND CONSEQUENCES THEREOF
05/17/2001WO2001007471A9 Cell cycle and proliferation proteins
05/17/2001WO2001001973A8 Highly selective norepinephrine reuptake inhibitors and methods of using the same
05/17/2001WO2001001932A3 Oligosaccharide aldonic acids and their topical use
05/17/2001WO2000077166A3 Gene expression modulated in gastrointestinal inflammation
05/17/2001WO2000076457A3 Il-8 receptor antagonists
05/17/2001WO2000040613A9 Insulin-like growth factor (igf) i mutant variants
05/17/2001WO1999044620A9 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
05/17/2001DE19954707A1 Imidazolverbindungen als Phosphodiesterase VII-Hemmer Imidazole compounds as phosphodiesterase VII inhibitor
05/17/2001DE19954490A1 Reducing salmonellosis in poultry and ornamental birds, by administering competitive lactic acid bacteria isolated from birds
05/17/2001DE19953899A1 Carboxamid-substituierte Benzimidazolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Carboxamide-substituted benzimidazole derivatives, processes for their preparation and their use as medicaments
05/17/2001CA2391415A1 Methods of treating inflammatory bowel disease using cholera toxin b subunit
05/17/2001CA2391278A1 Therapeutic compositions and methods of use thereof
05/17/2001CA2390880A1 Aralkyl-1,2-diamines having calcimimetic activity and preparation mode
05/17/2001CA2390496A1 Polycycloalkylpurines as adenosine receptor antagonists
05/17/2001CA2390438A1 19 human secreted proteins
05/17/2001CA2390421A1 24 human secreted proteins
05/17/2001CA2389982A1 Inhibition of pathogens by bacillus coagulans strains
05/17/2001CA2389724A1 28 human secreted proteins